No Stay For Apotex Amid Sanofi's Plavix Damages Push

Law360, New York (April 15, 2010, 7:40 PM EDT) -- Reasoning that a stay “at this late stage” would prejudice the plaintiff, a federal judge on Thursday denied Apotex Inc.'s bid to stay an infringement action, now in its damages stage, brought by Sanofi-Aventis SA over the blockbuster blood-thinning drug Plavix.

Judge Sidney H. Stein's order, issued in the U.S. District Court for the Southern District of New York, said that the stay sought by Apotex, which would put the case on hold until the patent-in-suit was reexamined, would not simplify the remaining issue of damages....
To view the full article, register now.